Key Points
HYDERABAD, Aug 7 (Reuters) - Indian generic injectables maker Gland Pharma Ltd (GLAD.NS) reported a 41% jump in first-quarter revenue on Monday, aided by its acquisition of French pharmaceutical group Cenexi...
The Hyderabad-based company, which draws the bulk of its revenue from the United States, Europe, Canada, Australia and New Zealand, said revenue jumped to 12.09 billion Indian rupees ($146.13 million) from 8.57 billion rupees...
The company said 37% of the total revenue came from its acquisition of Cenexi in January..
Excluding the Cenexi acquisition, Gland Pharma's revenue rose 3.5% on the back of improvement in its base business and stability in the United States...
You might be interested in
India's Cello World surges 29% on listing at $2.1 bln valuation
06, Nov, 23Shares of Indian kitchenware products maker Cello World (CELO.NS) rose as much as 29.2% in their trading debut on Monday, valuing the company at 177.72 billion rupees ($2.14 billion).
Hindustan Aeronautics first-quarter profit rises 31% on higher revenue
11, Aug, 23Hindustan Aeronautics Limited (HAL) (HIAE.NS) posted a 31% rise in first-quarter profit on Friday as fullfillment of orders helped boost aerospace and defense equipment maker's revenue.
India's Container Corp Q1 profit falls as costs rise, revenue slip
10, Aug, 23State-owned Container Corporation of India reported a more than 17% fall in first-quarter profit on Thursday after costs increased and revenue fell.
India's Tata Elxsi posts Q3 profit rise on strength in transportation segment
23, Jan, 24(Reuters) - Indian design and technology services company Tata Elxsi reported a 6% rise in third-quarter profit on Tuesday, helped by healthy demand in its transportation segment. The company's net